French guidelines from the GTE, AFCE and ENDOCAN-RENATEN (Groupe d'étude des Tumeurs Endocrines/Association Francophone de Chirurgie Endocrinienne/Reseau national de prise en charge des tumeurs endocrines) for the screening, diagnosis and management of Multiple Endocrine Neoplasia Type 1
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:85 |
---|---|
Enthalten in: |
Annales d'endocrinologie - 85(2024), 1 vom: 01. Feb., Seite 2-19 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Goudet, Pierre [VerfasserIn] |
---|
Links: |
---|
Themen: |
Multiple endocrine neoplasia |
---|
Anmerkungen: |
Date Completed 26.02.2024 Date Revised 26.02.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.ando.2023.09.003 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM362356343 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM362356343 | ||
003 | DE-627 | ||
005 | 20240229154441.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.ando.2023.09.003 |2 doi | |
028 | 5 | 2 | |a pubmed24n1306.xml |
035 | |a (DE-627)NLM362356343 | ||
035 | |a (NLM)37739121 | ||
035 | |a (PII)S0003-4266(23)00707-2 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Goudet, Pierre |e verfasserin |4 aut | |
245 | 1 | 0 | |a French guidelines from the GTE, AFCE and ENDOCAN-RENATEN (Groupe d'étude des Tumeurs Endocrines/Association Francophone de Chirurgie Endocrinienne/Reseau national de prise en charge des tumeurs endocrines) for the screening, diagnosis and management of Multiple Endocrine Neoplasia Type 1 |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 26.02.2024 | ||
500 | |a Date Revised 26.02.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Practice Guideline | |
650 | 4 | |a Multiple endocrine neoplasia | |
650 | 4 | |a Neuroendocrine tumors | |
650 | 4 | |a Parathyroid | |
650 | 4 | |a Pituitary | |
650 | 4 | |a Surgery | |
700 | 1 | |a Cadiot, Guillaume |e verfasserin |4 aut | |
700 | 1 | |a Barlier, Anne |e verfasserin |4 aut | |
700 | 1 | |a Baudin, Eric |e verfasserin |4 aut | |
700 | 1 | |a Borson-Chazot, Françoise |e verfasserin |4 aut | |
700 | 1 | |a Brunaud, Laurent |e verfasserin |4 aut | |
700 | 1 | |a Caiazzo, Robert |e verfasserin |4 aut | |
700 | 1 | |a Cardot-Bauters, Catherine |e verfasserin |4 aut | |
700 | 1 | |a Castinetti, Frédéric |e verfasserin |4 aut | |
700 | 1 | |a Chanson, Philippe |e verfasserin |4 aut | |
700 | 1 | |a Cuny, Thomas |e verfasserin |4 aut | |
700 | 1 | |a Dansin, Eric |e verfasserin |4 aut | |
700 | 1 | |a Gaujoux, Sébastien |e verfasserin |4 aut | |
700 | 1 | |a Giraud, Sophie |e verfasserin |4 aut | |
700 | 1 | |a Groussin, Lionel |e verfasserin |4 aut | |
700 | 1 | |a Le Bras, Maëlle |e verfasserin |4 aut | |
700 | 1 | |a Lifante, Jean-Christophe |e verfasserin |4 aut | |
700 | 1 | |a Mathonnet, Muriel |e verfasserin |4 aut | |
700 | 1 | |a de Mestier, Louis |e verfasserin |4 aut | |
700 | 1 | |a Mirallié, Eric |e verfasserin |4 aut | |
700 | 1 | |a Pattou, François |e verfasserin |4 aut | |
700 | 1 | |a Romanet, Pauline |e verfasserin |4 aut | |
700 | 1 | |a Sebag, Frédéric |e verfasserin |4 aut | |
700 | 1 | |a Tresallet, Christophe |e verfasserin |4 aut | |
700 | 1 | |a Vezzosi, Delphine |e verfasserin |4 aut | |
700 | 1 | |a Walter, Thomas |e verfasserin |4 aut | |
700 | 1 | |a Tabarin, Antoine |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Annales d'endocrinologie |d 1946 |g 85(2024), 1 vom: 01. Feb., Seite 2-19 |w (DE-627)NLM000173932 |x 2213-3941 |7 nnns |
773 | 1 | 8 | |g volume:85 |g year:2024 |g number:1 |g day:01 |g month:02 |g pages:2-19 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ando.2023.09.003 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 85 |j 2024 |e 1 |b 01 |c 02 |h 2-19 |